Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights
· manilatimes.net
- Entitles holders to receive net proceeds from sale of remaining Legacy Biosimilar Assets -
- Entitles holders to receive net proceeds from sale of remaining Legacy Biosimilar Assets -
- Completes transformation of Coherus Oncology into a fully integr...